Intra-Cellular Therapies revenue

Intra-Cellular Therapies revenue decreased from $245.8 thousand in 2017 to $0 in 2018, a 100% decrease.

Intra-Cellular Therapies revenue was $245.84 k in FY, 2017

	FY, 2013	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	$2.74 m	$2.74 m	$577.30 k	$91.36 k	$330.70 k	$245.84 k
Growth			(78.91%)	(84.17%)	261.96%

	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Revenue	$667.96 k	$167.79 k	$219.24 k	$124.41 k	$3.32 k	$57.39 k	$124.41 k	$3.32 k	$228.45 k	$4.36 k	$95.29 k	$114.74 k	$30.75 k

Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue

	FY, 2014	FY, 2015
License and collaboration revenue	547.55 k	30.66 k
Grant Revenue	29.76 k	60.71 k

Need Data?